Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0007
Evaluation of 3 Hour Infusion of Paclitaxel Plus Cisplatin and 5-Fluorouracil in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Research Committee(s)
Head and Neck Cancer
Activated
11-01-2000
Closed
05-15-2003
Closed
Phase
Accrual
2%
Published
SWOG Clinical Trial Number
S0019
A Randomized Phase III Trial of ICE Chemotherapy With or Without Rituximab for the Treatment of Relapsed or Refractory CD20 Expressing Agressive B-Cell Non-Hodgkin's Lymphomas in Patients Not Suitable for High Dose Therapy and PBSCT.
Research Committee(s)
Lymphoma
Activated
10-15-2000
Closed
12-15-2001
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
S0004
A Phase I Study of Tirapazamine/Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
10-15-2000
Closed
04-01-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9912
Phase II Evaluation of Intravenous Paclitaxel, Intraperitoneal Cisplatin, Intravenous Liposomal Doxorubicin and Intraperitoneal Paclitaxel in Women with Optimally-Debulked Stage III Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Research Committee(s)
Gynecologic Cancer
Activated
10-01-2000
Closed
08-15-2005
Closed
Phase
Accrual
36%
Published
SWOG Clinical Trial Number
S0013
Evaluation of In Vitro Assays as Predictors of Clinical Outcome in Patients With Locally Advanced (Stage IIB-IVA)Cervical Carcinoma, Biologic
Research Committee(s)
Gynecologic Cancer
Activated
09-15-2000
Closed
11-15-2003
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
S0008
Phase III Trial of High Dose Interferon Alpha-2b versus Cisplatin, Vinblastine, DTIC Plus IL-2 and Interferon in Patients with High Risk Melanoma
Research Committee(s)
Melanoma
Activated
08-01-2000
Closed
11-15-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9923
A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Colorectal Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
08-01-2001
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S9924
A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Pancreas Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
06-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0014
Evaluation of CHOP Plus Rituximab Plus Involved Field Radiotherapy for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High Risk Localized Aggressive Histologies of Non-Hodgkin’s Lymphoma, Phase II
Research Committee(s)
Lymphoma
Activated
04-01-2000
Closed
01-15-2002
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
S9917
L-Selenium-Based Chemoprevention of Prostate Cancer Among Men with High Grade Prostatic Intraepithelial Neoplasia
Activated
02-01-2000
Closed
11-01-2006
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S9902
Evaluation of the Combination of Docetaxel (Taxotere®)/ Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN), Phase II
Research Committee(s)
Head and Neck Cancer
Activated
11-15-1999
Closed
01-01-2001
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
S9900
A Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB(T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC).
Research Committee(s)
Lung Cancer
Activated
10-15-1999
Closed
07-15-2004
Closed
Phase
Accrual
99%
Published
SWOG Clinical Trial Number
S9914
Phase II Trial of Paclitaxel, Carboplatin and Topotecan with G-CSF in Untreated Patients with Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
10-15-1999
Closed
06-15-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9916
Docetaxel and Estramustine Versus Mitoxantrone and Prednisone for Advanced, Hormone Refractory Prostate Cancer, Phase III.
Research Committee(s)
Genitourinary Cancer
Activated
10-15-1999
Closed
01-15-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9812
Pilot Study of l-Selenomethionine in Prostate Cancer Patients Scheduled to Undergo Radical Prostatectomy
Activated
06-15-1999
Closed
06-01-2001
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
S9804
Evaluation of Vinorelbine Tartrate (Navelbine®) in Patients with Disseminated Malignant Melanoma and at Least One Prior Systemic Therapy, Phase II.
Research Committee(s)
Melanoma
Activated
05-15-1999
Closed
08-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9911
A Phase II Pilot Trial of CHOP Followed By Iodine-131-Labeled Monoclonal Anti-B1 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin’s Lymphomas
Research Committee(s)
Lymphoma
Activated
05-15-1999
Closed
06-01-2000
Closed
Phase
Accrual
13%
Published
SWOG Clinical Trial Number
S9809
The Effect of Fluoroquinolones on the Disease-Free Interval in Patients with Stage Ta Transitional Cell Carcinoma of the Bladder, Phase III
Research Committee(s)
Genitourinary Cancer
Activated
04-15-1999
Closed
07-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9810
A Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma
Research Committee(s)
Sarcoma
Activated
02-15-1999
Closed
08-15-2000
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
S9811
Phase II Study of Hydroxyurea for Unresectable Meningioma
Activated
11-15-1998
Closed
06-01-2005